Mäkinen Mia, Forsström Jari, Aärimaa Markku, Rautava Päivi
Public Health Department, University of Turku, Turku, Finland.
Telemed J E Health. 2006 Aug;12(4):484-9. doi: 10.1089/tmj.2006.12.484.
This study investigated the possibilities and obstacles for cross-border electronic prescriptions within the European internal market. Cross-border electronic prescribing requires interoperability of the systems and use of standardized solutions. We conducted a survey-based case study. A questionnaire on the use of electronic prescriptions was sent by e-mail to the delegates from 14 European Union (EU) member countries and 2 European Economic Area (EEA) countries during spring-summer 2003. A reply was received from 11 delegates in 11 countries contacted. Currently electronic prescriptions are in everyday use in only a few EU member countries, while many others are running or considering pilot projects. We found that electronic prescribing across national borders is impeded by many obstacles, which may relate to other systems or to lack of standardization. Information technology is likely to gradually spread to prescribing in Europe. Before more countries will integrate electronic prescribing into national healthcare, it would be important to ensure interoperability and common standards between national systems. Only then can electronic prescribing offer its full potential, and cross-border electronic prescribing can be realized at the EU level.
本研究调查了欧洲内部市场跨境电子处方的可能性和障碍。跨境电子处方需要系统的互操作性和标准化解决方案的使用。我们进行了一项基于调查的案例研究。2003年春夏期间,通过电子邮件向来自14个欧盟成员国和2个欧洲经济区国家的代表发送了一份关于电子处方使用情况的问卷。在联系的11个国家中,收到了11位代表的回复。目前电子处方仅在少数欧盟成员国日常使用,而许多其他国家正在开展或考虑开展试点项目。我们发现,跨境电子处方受到许多障碍的阻碍,这些障碍可能与其他系统有关,也可能与缺乏标准化有关。信息技术可能会逐渐在欧洲推广到处方开具领域。在更多国家将电子处方纳入国家医疗保健体系之前,确保国家系统之间的互操作性和共同标准非常重要。只有这样,电子处方才能充分发挥其潜力,欧盟层面的跨境电子处方才能实现。